Means and methods for the specific inhibition of genes in cells and tissue of the CNS and/or eye

Details for Australian Patent Application No. 2003224087 (hide)

International Classifications

Event Publications

7 August 2003 Complete Application Filed

Priority application(s): 02008761.5 18.04.02 EP; 60/431,173 05.12.02 US

4 December 2003 Application Open to Public Inspection

Published as AU-B-2003224087

24 February 2005 Assignment before Grant

Lynkeus Biotech GmbH The application has been assigned to Acuity Pharmaceuticals, Inc.

5 March 2009 Application Accepted

Published as AU-B-2003224087

2 April 2009 Assignment before Grant

Acuity Pharmaceuticals, Inc. The application has been assigned to OPKO Ophthalmics, LLC.

2 July 2009 Standard Patent Sealed

1 November 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read OPKO Pharmaceuticals, LLC. . Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden Canberra ACT 2606

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.